78
Participants
Start Date
January 31, 2015
Primary Completion Date
May 31, 2016
Study Completion Date
June 30, 2016
AUT00063
600 mg, orally, once a day, for 4 weeks
Placebo
orally, once a day, for 4 weeks
Long Island Jewish Medical Center, New Hyde Park
Piedmont Ear, Nose, & Throat Associates, Winston-Salem
PMG Research Inc., Wilmington
QPS MRA (Miami Research Associates), Miami
ENT Associates of South Florida, Boca Raton
University of South Florida, Tampa
Vanderbilt University Medical Center, Nashville
The University of Mississippi Medical Center, Jackson
University of Louisville, Louisville
Mayo Clinic, Rochester
Colorado ENT and Allergy, Colorado Springs
Jean Brown Research, Murray
Sacramento ENT, Sacramento
Lead Sponsor
Autifony Therapeutics Limited
INDUSTRY